Clioquinol inhibits dopamine-β-hydroxylase secretion and noradrenaline synthesis by affecting the redox status of ATOX1 and copper transport in human neuroblastoma SH-SY5Y cells-Reference-Cited by-同舟云学术

Clioquinol inhibits dopamine-β-hydroxylase secretion and noradrenaline synthesis by affecting the redox status of ATOX1 and copper transport in human neuroblastoma SH-SY5Y cells

Published:2020-10-09 Issue:1 Volume:95 Page:135-148
ISSN:0340-5761
Container-title:Archives of Toxicology
language:en
Short-container-title:Arch Toxicol

Author:

Katsuyama Masato^ORCID,Kimura En,Ibi Masakazu,Iwata Kazumi,Matsumoto Misaki,Asaoka Nozomi,Yabe-Nishimura Chihiro

Funder

Ministry of Health, Labour and Welfare

Publisher

Springer Science and Business Media LLC

Subject

Health, Toxicology and Mutagenesis,Toxicology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00204-020-02894-0.pdf

Reference52 articles.

1. Andersson DA, Gentry C, Moss S, Bevan S (2009) Clioquinol and pyrithione activate TRPA1 by increasing intracellular Zn2+. Proc Natl Acad Sci USA 106(20):8374–8379. https://doi.org/10.1073/pnas.0812675106

2. Asakura K, Ueda A, Kawamura N, Ueda M, Mihara T, Mutoh T (2009) Clioquinol inhibits NGF-induced Trk autophosphorylation and neurite outgrowth in PC12 cells. Brain Res 1301:110–115. https://doi.org/10.1016/j.brainres.2009.09.011

3. Badarau A, Basle A, Firbank SJ, Dennison C (2013) Crosstalk between Cu(I) and Zn(II) homeostasis via Atx1 and cognate domains. Chem Commun (Camb) 49(73):8000–8002. https://doi.org/10.1039/c3cc42709a

4. Bareggi SR, Cornelli U (2012) Clioquinol: review of its mechanisms of action and clinical uses in neurodegenerative disorders. CNS Neurosci Ther 18(1):41–46. https://doi.org/10.1111/j.1755-5949.2010.00231.x

5. Benvenisti-Zarom L, Chen J, Regan RF (2005) The oxidative neurotoxicity of clioquinol. Neuropharmacology 49(5):687–694. https://doi.org/10.1016/j.neuropharm.2005.04.023

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. α-Lipoic acid: a potential regulator of copper metabolism in Alzheimer’s disease;Frontiers in Molecular Biosciences;2024-09-03

2. Loss‐of‐function polymorphisms in NQO1 are not associated with the development of subacute myelo‐optico‐neuropathy;Molecular Genetics & Genomic Medicine;2024-06

3. The physiological and pathophysiological roles of copper in the nervous system;European Journal of Neuroscience;2024-05-15

4. Toward the complete understanding of the pathogenic mechanism of clioquinol-induced subacute myelo-optic neuropathy (SMON);Folia Pharmacologica Japonica;2024-03-01

5. Evaluation the role of cuproptosis-related genes in the pathogenesis, diagnosis and molecular subtypes identification of atherosclerosis;Heliyon;2023-10